Cargando…

Point of care testing evaluation of lateral flow immunoassay for diagnosis of cryptococcus meningitis in HIV-positive patients at an urban hospital in Nairobi, Kenya, 2017

OBJECTIVES: The objective of this study was to evaluate the performance of lateral flow immunoassay (LFA) against latex agglutination (LA), India ink and culture in point-of-care diagnosis of cryptococcus meningitis (CM). We conducted cross-sectional study among HIV-positive patients with suspected...

Descripción completa

Detalles Bibliográficos
Autores principales: Gitonga, Lawrence Kirimi, Boru, Waqo Gufu, Kwena, Arthur, Maritim, Marybeth, Wamicwe, Joyce, Ransom, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896259/
https://www.ncbi.nlm.nih.gov/pubmed/31806044
http://dx.doi.org/10.1186/s13104-019-4829-4
_version_ 1783476739464232960
author Gitonga, Lawrence Kirimi
Boru, Waqo Gufu
Kwena, Arthur
Maritim, Marybeth
Wamicwe, Joyce
Ransom, James
author_facet Gitonga, Lawrence Kirimi
Boru, Waqo Gufu
Kwena, Arthur
Maritim, Marybeth
Wamicwe, Joyce
Ransom, James
author_sort Gitonga, Lawrence Kirimi
collection PubMed
description OBJECTIVES: The objective of this study was to evaluate the performance of lateral flow immunoassay (LFA) against latex agglutination (LA), India ink and culture in point-of-care diagnosis of cryptococcus meningitis (CM). We conducted cross-sectional study among HIV-positive patients with suspected CM at Mbagathi Hospital, Nairobi, April–July 2017. RESULTS: Of 124 capillary blood and serum and 99 cerebrospinal fluid (CSF) samples, LFA and LA had a concurrence on serum of 94.4%, kappa (0.88), sensitivity (100%) and specificity (91%). LFA and LA on CSF, was 97.9%, kappa (0.96), sensitivity (100%) and specificity (96%). LFA and India ink was 96.9%, kappa (0.94), sensitivity (100%) and specificity (94.1%). On CSF culture, concurrence was 72.7%, kappa (0.43), sensitivity (100%) and specificity (64%) and of LFA on capillary blood, serum and CSF was 100% with kappa (1.00), sensitivity and specificity of 100%.
format Online
Article
Text
id pubmed-6896259
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68962592019-12-11 Point of care testing evaluation of lateral flow immunoassay for diagnosis of cryptococcus meningitis in HIV-positive patients at an urban hospital in Nairobi, Kenya, 2017 Gitonga, Lawrence Kirimi Boru, Waqo Gufu Kwena, Arthur Maritim, Marybeth Wamicwe, Joyce Ransom, James BMC Res Notes Research Note OBJECTIVES: The objective of this study was to evaluate the performance of lateral flow immunoassay (LFA) against latex agglutination (LA), India ink and culture in point-of-care diagnosis of cryptococcus meningitis (CM). We conducted cross-sectional study among HIV-positive patients with suspected CM at Mbagathi Hospital, Nairobi, April–July 2017. RESULTS: Of 124 capillary blood and serum and 99 cerebrospinal fluid (CSF) samples, LFA and LA had a concurrence on serum of 94.4%, kappa (0.88), sensitivity (100%) and specificity (91%). LFA and LA on CSF, was 97.9%, kappa (0.96), sensitivity (100%) and specificity (96%). LFA and India ink was 96.9%, kappa (0.94), sensitivity (100%) and specificity (94.1%). On CSF culture, concurrence was 72.7%, kappa (0.43), sensitivity (100%) and specificity (64%) and of LFA on capillary blood, serum and CSF was 100% with kappa (1.00), sensitivity and specificity of 100%. BioMed Central 2019-12-05 /pmc/articles/PMC6896259/ /pubmed/31806044 http://dx.doi.org/10.1186/s13104-019-4829-4 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Note
Gitonga, Lawrence Kirimi
Boru, Waqo Gufu
Kwena, Arthur
Maritim, Marybeth
Wamicwe, Joyce
Ransom, James
Point of care testing evaluation of lateral flow immunoassay for diagnosis of cryptococcus meningitis in HIV-positive patients at an urban hospital in Nairobi, Kenya, 2017
title Point of care testing evaluation of lateral flow immunoassay for diagnosis of cryptococcus meningitis in HIV-positive patients at an urban hospital in Nairobi, Kenya, 2017
title_full Point of care testing evaluation of lateral flow immunoassay for diagnosis of cryptococcus meningitis in HIV-positive patients at an urban hospital in Nairobi, Kenya, 2017
title_fullStr Point of care testing evaluation of lateral flow immunoassay for diagnosis of cryptococcus meningitis in HIV-positive patients at an urban hospital in Nairobi, Kenya, 2017
title_full_unstemmed Point of care testing evaluation of lateral flow immunoassay for diagnosis of cryptococcus meningitis in HIV-positive patients at an urban hospital in Nairobi, Kenya, 2017
title_short Point of care testing evaluation of lateral flow immunoassay for diagnosis of cryptococcus meningitis in HIV-positive patients at an urban hospital in Nairobi, Kenya, 2017
title_sort point of care testing evaluation of lateral flow immunoassay for diagnosis of cryptococcus meningitis in hiv-positive patients at an urban hospital in nairobi, kenya, 2017
topic Research Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896259/
https://www.ncbi.nlm.nih.gov/pubmed/31806044
http://dx.doi.org/10.1186/s13104-019-4829-4
work_keys_str_mv AT gitongalawrencekirimi pointofcaretestingevaluationoflateralflowimmunoassayfordiagnosisofcryptococcusmeningitisinhivpositivepatientsatanurbanhospitalinnairobikenya2017
AT boruwaqogufu pointofcaretestingevaluationoflateralflowimmunoassayfordiagnosisofcryptococcusmeningitisinhivpositivepatientsatanurbanhospitalinnairobikenya2017
AT kwenaarthur pointofcaretestingevaluationoflateralflowimmunoassayfordiagnosisofcryptococcusmeningitisinhivpositivepatientsatanurbanhospitalinnairobikenya2017
AT maritimmarybeth pointofcaretestingevaluationoflateralflowimmunoassayfordiagnosisofcryptococcusmeningitisinhivpositivepatientsatanurbanhospitalinnairobikenya2017
AT wamicwejoyce pointofcaretestingevaluationoflateralflowimmunoassayfordiagnosisofcryptococcusmeningitisinhivpositivepatientsatanurbanhospitalinnairobikenya2017
AT ransomjames pointofcaretestingevaluationoflateralflowimmunoassayfordiagnosisofcryptococcusmeningitisinhivpositivepatientsatanurbanhospitalinnairobikenya2017